ArticleScientific reports2025

Super-enhancer-driven SLCO4A1-AS1 is a new biomarker and a promising therapeutic target in glioblastoma.

Yibo Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.